...
首页> 外文期刊>Cancer science. >Photodynamic therapy using nanoparticle loaded with indocyanine green for experimental peritoneal dissemination of gastric cancer
【24h】

Photodynamic therapy using nanoparticle loaded with indocyanine green for experimental peritoneal dissemination of gastric cancer

机译:使用负载吲哚菁绿的纳米粒子进行光动力疗法治疗胃癌的腹膜扩散

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Although there have been multiple advances in the development of novel anticancer agents and operative procedures, prognosis of patients with advanced gastric cancer remains poor, especially in patients with peritoneal metastasis. In this study, we established nanoparticles loaded with indocyanine green (ICG) derivatives: ICG loaded lactosomes (ICGm) and investigated the diagnostic and therapeutic value of photodynamic therapy (PDT) using ICGm for experimental peritoneal dissemination of gastric cancer. Experimental peritoneal disseminated xenografts of human gastric cancer were established in nude mice. Three weeks after intraperitoneal injection of the cancer cells, either ICGm (ICGm-treated mice) or ICG solution (ICG-treated mice) was injected through the tail vein. Forty-eight hours after injection of the photosensitizer, in vivo and ex vivo imaging was carried out. For PDT, 48h after injection of the photosensitizer, other mice were irradiated through the abdominal wall, and the body weight and survival rate were monitored. In vivo imaging revealed that peritoneal tumors were visualized through the abdominal wall in ICGm-treated mice, whereas only non-specific fluorescence was observed in ICG-treated mice. The PDT reduced the total weight of the disseminated nodules and significantly improved weight loss and survival rate in ICGm-treated mice. In conclusion, ICGm can be used as a novel diagnostic and therapeutic nanodevice in peritoneal dissemination of gastric cancer.
机译:尽管新型抗癌药和手术方法的开发取得了多项进展,但晚期胃癌患者的预后仍然很差,尤其是腹膜转移患者。在这项研究中,我们建立了负载吲哚菁绿(ICG)衍生物的纳米颗粒:负载ICG的乳糖体(ICGm),并研究了使用ICGm进行光动力疗法(PDT)对胃癌的实验性腹膜扩散的诊断和治疗价值。在裸鼠中建立了实验性腹膜播散的人胃癌异种移植物。腹膜内注射癌细胞三周后,通过尾静脉注射ICGm(ICGm处理的小鼠)或ICG溶液(ICG处理的小鼠)。注射光敏剂后四十八小时,进行体内和体外成像。对于PDT,在注射光敏剂后48小时,通过腹壁照射其他小鼠,并监测体重和存活率。体内成像显示,在ICGm治疗的小鼠中,腹膜肿瘤通过腹壁可见,而在ICG治疗的小鼠中仅观察到非特异性荧光。 PDT降低了弥散性结节的总重量,并显着改善了ICGm治疗小鼠的体重减轻和存活率。总之,ICGm可作为一种新型的诊断和治疗性纳米器件,用于胃癌的腹膜扩散。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号